SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Brogna C)
 

Sökning: WFRF:(Brogna C) > The EU-AIMS Longitu...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006813naa a2201213 4500
001oai:DiVA.org:uu-325671
003SwePub
008170627s2017 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:136090654
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3256712 URI
024a https://doi.org/10.1186/s13229-017-0146-82 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1360906542 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Loth, Eva4 aut
2451 0a The EU-AIMS Longitudinal European Autism Project (LEAP) :b design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders.
264 c 2017-06-23
264 1b Springer Science and Business Media LLC,c 2017
338 a electronic2 rdacarrier
520 a BACKGROUND: The tremendous clinical and aetiological diversity among individuals with autism spectrum disorder (ASD) has been a major obstacle to the development of new treatments, as many may only be effective in particular subgroups. Precision medicine approaches aim to overcome this challenge by combining pathophysiologically based treatments with stratification biomarkers that predict which treatment may be most beneficial for particular individuals. However, so far, we have no single validated stratification biomarker for ASD. This may be due to the fact that most research studies primarily have focused on the identification of mean case-control differences, rather than within-group variability, and included small samples that were underpowered for stratification approaches. The EU-AIMS Longitudinal European Autism Project (LEAP) is to date the largest multi-centre, multi-disciplinary observational study worldwide that aims to identify and validate stratification biomarkers for ASD.METHODS: LEAP includes 437 children and adults with ASD and 300 individuals with typical development or mild intellectual disability. Using an accelerated longitudinal design, each participant is comprehensively characterised in terms of clinical symptoms, comorbidities, functional outcomes, neurocognitive profile, brain structure and function, biochemical markers and genomics. In addition, 51 twin-pairs (of which 36 had one sibling with ASD) are included to identify genetic and environmental factors in phenotypic variability.RESULTS: Here, we describe the demographic characteristics of the cohort, planned analytic stratification approaches, criteria and steps to validate candidate stratification markers, pre-registration procedures to increase transparency, standardisation and data robustness across all analyses, and share some 'lessons learnt'. A clinical characterisation of the cohort is given in the companion paper (Charman et al., accepted).CONCLUSION: We expect that LEAP will enable us to confirm, reject and refine current hypotheses of neurocognitive/neurobiological abnormalities, identify biologically and clinically meaningful ASD subgroups, and help us map phenotypic heterogeneity to different aetiologies.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Psykiatri0 (SwePub)302152 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Psychiatry0 (SwePub)302152 hsv//eng
653 a Biomarkers
653 a Cognition
653 a EEG
653 a Eye-tracking
653 a Genetics
653 a MRI
653 a Neuroimaging
700a Charman, Tony4 aut
700a Mason, Luke4 aut
700a Tillmann, Julian4 aut
700a Jones, Emily J H4 aut
700a Wooldridge, Caroline4 aut
700a Ahmad, Jumana4 aut
700a Auyeung, Bonnie4 aut
700a Brogna, Claudia4 aut
700a Ambrosino, Sara4 aut
700a Banaschewski, Tobias4 aut
700a Baron-Cohen, Simon4 aut
700a Baumeister, Sarah4 aut
700a Beckmann, Christian4 aut
700a Brammer, Michael4 aut
700a Brandeis, Daniel4 aut
700a Bölte, Svenu Karolinska Institutet4 aut
700a Bourgeron, Thomas4 aut
700a Bours, Carsten4 aut
700a de Bruijn, Yvette4 aut
700a Chakrabarti, Bhismadev4 aut
700a Crawley, Daisy4 aut
700a Cornelissen, Ineke4 aut
700a Acqua, Flavio Dell'4 aut
700a Dumas, Guillaume4 aut
700a Durston, Sarah4 aut
700a Ecker, Christine4 aut
700a Faulkner, Jessica4 aut
700a Frouin, Vincent4 aut
700a Garces, Pilar4 aut
700a Goyard, David4 aut
700a Hayward, Hannah4 aut
700a Ham, Lindsay M4 aut
700a Hipp, Joerg4 aut
700a Holt, Rosemary J4 aut
700a Johnson, Mark H4 aut
700a Isaksson, Johanu Karolinska Institutet,Uppsala universitet,Barn- och ungdomspsykiatri,Karolinska Inst KIND, Ctr Neurodev Disorders, Stockholm, Sweden4 aut0 (Swepub:uu)johis856
700a Kundu, Prantik4 aut
700a Lai, Meng-Chuan4 aut
700a D'ardhuy, Xavier Liogier4 aut
700a Lombardo, Michael V4 aut
700a Lythgoe, David J4 aut
700a Mandl, René4 aut
700a Meyer-Lindenberg, Andreas4 aut
700a Moessnang, Carolin4 aut
700a Mueller, Nico4 aut
700a O'Dwyer, Laurence4 aut
700a Oldehinkel, Marianne4 aut
700a Oranje, Bob4 aut
700a Pandina, Gahan4 aut
700a Persico, Antonio M4 aut
700a Ruigrok, Amber N V4 aut
700a Ruggeri, Barbara4 aut
700a Sabet, Jessica4 aut
700a Sacco, Roberto4 aut
700a Cáceres, Antonia San José4 aut
700a Simonoff, Emily4 aut
700a Toro, Roberto4 aut
700a Tost, Heike4 aut
700a Waldman, Jack4 aut
700a Williams, Steve C R4 aut
700a Zwiers, Marcel P4 aut
700a Spooren, Will4 aut
700a Murphy, Declan G M4 aut
700a Buitelaar, Jan K4 aut
710a Karolinska Institutetb Barn- och ungdomspsykiatri4 org
773t Molecular Autismd : Springer Science and Business Media LLCg 8q 8x 2040-2392
856u https://doi.org/10.1186/s13229-017-0146-8y Fulltext
856u https://uu.diva-portal.org/smash/get/diva2:1115617/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://molecularautism.biomedcentral.com/track/pdf/10.1186/s13229-017-0146-8
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-325671
8564 8u https://doi.org/10.1186/s13229-017-0146-8
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:136090654

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy